Laboratory Corporation of... (LH)
NYSE: LH
· Real-Time Price · USD
248.82
2.07 (0.84%)
At close: May 30, 2025, 3:59 PM
248.01
-0.33%
After-hours: May 30, 2025, 05:27 PM EDT
Laboratory of America Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2021 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|
| LabCorp Diagnostics Revenue | 10.14B | 9.42B | 10.36B | 6.66B | 6.66B | 14.34B | 6.59B | 6.2B | 5.47B |
| LabCorp Diagnostics Revenue Growth | +7.75% | -9.15% | +55.55% | -0.03% | -53.53% | +117.49% | +6.37% | +13.43% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|
| Europe Revenue | 2.05B | 1.51B | 1.2B | 1.18B | 857.7M |
| Europe Revenue Growth | +35.62% | +26.05% | +1.55% | +37.74% | n/a |
| North America Revenue | 13.09B | 11.53B | n/a | n/a | n/a |
| North America Revenue Growth | +13.61% | n/a | n/a | n/a | n/a |
| Other Countries Revenue | 976.4M | 941M | n/a | n/a | n/a |
| Other Countries Revenue Growth | +3.76% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 546M | 595.2M | 568.6M | 557.8M | 508.4M | 532.9M | 525.5M | 505.8M | 553.6M | 536.5M | 510M | 486M | 464.1M | 543.7M | 519.9M | 458.7M | 429.8M | 518M | 419.5M | 396.3M | 395.5M | 413.9M | 401.5M | 415.3M | 393.8M | 396.9M | 381.8M | 395.2M | 397M | 492.4M | 465.3M | 435.3M | 419.4M | 406M | 400.5M | 408M | 411.9M | 404.9M | 382.5M | 392.4M | 415.1M |
| Selling, General, and Administrative Revenue Growth | -8.27% | +4.68% | +1.94% | +9.72% | -4.60% | +1.41% | +3.89% | -8.63% | +3.19% | +5.20% | +4.94% | +4.72% | -14.64% | +4.58% | +13.34% | +6.72% | -17.03% | +23.48% | +5.85% | +0.20% | -4.45% | +3.09% | -3.32% | +5.46% | -0.78% | +3.95% | -3.39% | -0.45% | -19.37% | +5.82% | +6.89% | +3.79% | +3.30% | +1.37% | -1.84% | -0.95% | +1.73% | +5.86% | -2.52% | -5.47% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |